Locations:

Blood Cancers

February 24, 2021/Cancer/Blood Cancers

Azacitidine Shows Potential as a Treatment for Multiple Myeloma

Trial results point the way to further investigation

January 20, 2021/Basic & Translational Science

Selective Targeting May Have Therapeutic Potential in TET2-Mutant Neoplasia

TETi76 eliminates TET2-mutant and TET-deficient cancer cells

January 7, 2021/Cancer/Blood Cancers

Pacritinib Moves Closer to FDA Approval for Myelofibrosis

Dose-finding trial adds to evidence of efficacy

December 29, 2020/Basic & Translational Science

Machine Learning Improves the Subclassification and Prognostication of Acute Myeloid Leukemia

Four genomic clusters identified

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

December 14, 2020/Cancer/Blood Cancers

Decision Support Tool Can Predict Patient Response to Treatment with Hypomethylating Agents

A major advance in prognosis for myelodysplastic syndromes that may improve outcomes

December 10, 2020/Basic & Translational Science

Metabolomic Screening Reveals Pre-Existing Signatures in Patients Treated with CAR T-Cell Therapy

Molecular markers could potentially predict major adverse side effects

October 28, 2020/Cancer/Blood Cancers

Standardizing Care for Central Nervous System Lymphoma

Emerging multidisciplinary program seeks better care, outcomes

August 17, 2020/Cancer/Blood Cancers

Eltrombopag Enhances Platelet Count Recovery in Older Patients with Acute Myeloid Leukemia

Promising phase 2 study results

BackPage 6 of 6Next